Примери за използване на Lenalidomide and dexamethasone на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
or placebo, lenalidomide and dexamethasone(N=362; placebo regimen)
Combination dosing with lenalidomide and dexamethasone did not affect proteasome inhibition.
Recommended dosing schedule of Empliciti in combination with lenalidomide and dexamethasone.
Combination treatment with lenalidomide and dexamethasone in patients ineligible for autologous stem cell transplant.
Dose adjustments for lenalidomide and dexamethasone were applied according to manufacturer's prescribing information.
refer to the current lenalidomide and dexamethasone SmPC.
1.9% of Empliciti combined with lenalidomide and dexamethasone and lenalidomide and dexamethasone treated patients, respectively.
9 are omitted if Kyprolis is used with lenalidomide and dexamethasone.
severe hepatic impairment were excluded from Kyprolis studies in combination with either lenalidomide and dexamethasone or dexamethasone alone.
It is given together with two other medicines, lenalidomide and dexamethasone, to patients who have received at least one prior treatment.
321 to Empliciti in combination with lenalidomide and dexamethasone and 325 to lenalidomide and dexamethasone. .
Second Primary Malignancies are known to be associated with lenalidomide exposure which was extended in patients treated with Empliciti combined with lenalidomide and dexamethasone vs. lenalidomide and dexamethasone.
As ixazomib is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional undesirable effects.
placebo in combination with lenalidomide and dexamethasone(intent-to-treat population).
Eligible patients were randomised in a 1:1 ratio to receive either Empliciti in combination with lenalidomide and dexamethasone or lenalidomide and dexamethasone(Ld).
Adverse reactions in patients treated with ixazomib in combination with lenalidomide and dexamethasone(all grades, grade 3
Thus, there are limited data for Kyprolis in combination with lenalidomide and dexamethasone in patients with creatinine clearance(CrCL< 50 mL/min).
It is used together with two other medicines(lenalidomide and dexamethasone) and is given to adults who have received at least one previous cancer treatment.
NINLARO in combination with lenalidomide and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
As ixazomib is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional special warnings